US Stock MarketDetailed Quotes

SRPT Sarepta Therapeutics

Watchlist
  • 126.530
  • +0.520+0.41%
Close Dec 4 16:00 ET
  • 126.450
  • -0.080-0.06%
Post 16:53 ET
12.09BMarket Cap82.16P/E (TTM)

Sarepta Therapeutics Key Stats

Sarepta Therapeutics Q3 2024 Earnings Date

Currency:USDNov 6, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
405.06M
467.17M
+62.11M
Beat Est.
+22.07%
+40.79%
+15.33%
EPS
-0.16
0.34
+0.50
Beat Est.
+65.01%
+173.91%
+311.31%
Strong Buy

Dec 4, 2024

Sarepta Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 708.957M--
--2024/Q4-- / 583.131M--
Nov 6, 20242024/Q3467.172M / 405.059M--
Aug 7, 20242024/Q2362.931M / 387.814M--
May 1, 20242024/Q1413.464M / 375.429M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 708.957M--
--2024/Q4-- / 583.131M--
Nov 6, 20242024/Q3467.172M / 405.059M--
Aug 7, 20242024/Q2362.931M / 387.814M--
May 1, 20242024/Q1413.464M / 375.429M--

Unlock Free Earnings Estimates

Sarepta Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Dec 4, 2024

Strong Buy

  • Buy

    95.46%
  • Hold

    0.00%
  • Sell

    4.55%

Price Target

No Data